Point72 DIFC Ltd Makes New Investment in agilon health, inc. (NYSE:AGL)

Point72 DIFC Ltd acquired a new stake in agilon health, inc. (NYSE:AGL) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 25,295 shares of the company’s stock, valued at approximately $99,000.

Other hedge funds also recently modified their holdings of the company. J.Safra Asset Management Corp boosted its holdings in agilon health by 626.1% in the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock valued at $27,000 after purchasing an additional 3,625 shares during the period. Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of agilon health in the third quarter valued at about $28,000. CWM LLC lifted its stake in shares of agilon health by 406.5% in the second quarter. CWM LLC now owns 9,081 shares of the company’s stock valued at $59,000 after buying an additional 7,288 shares during the period. Nisa Investment Advisors LLC acquired a new stake in agilon health during the second quarter worth about $60,000. Finally, Allspring Global Investments Holdings LLC increased its stake in agilon health by 17,790.0% during the second quarter. Allspring Global Investments Holdings LLC now owns 10,734 shares of the company’s stock valued at $70,000 after acquiring an additional 10,674 shares during the period.

agilon health Stock Down 1.8 %

Shares of NYSE AGL opened at $2.17 on Monday. agilon health, inc. has a 12-month low of $1.50 and a 12-month high of $13.76. The firm’s 50-day simple moving average is $2.57 and its 200 day simple moving average is $4.52. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. The company has a market cap of $894.08 million, a price-to-earnings ratio of -2.31 and a beta of 0.51.

agilon health (NYSE:AGL) last announced its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The company had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. During the same quarter in the previous year, the company posted ($0.06) earnings per share. On average, research analysts expect that agilon health, inc. will post -0.5 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on AGL shares. Citigroup decreased their price objective on agilon health from $2.50 to $1.75 and set a “sell” rating on the stock in a report on Wednesday, November 13th. Stifel Nicolaus decreased their price target on shares of agilon health from $7.00 to $2.00 and set a “hold” rating on the stock in a research note on Tuesday, November 12th. William Blair cut shares of agilon health from an “outperform” rating to a “market perform” rating in a research note on Friday, November 8th. Barclays decreased their target price on shares of agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a research report on Monday, November 11th. Finally, JMP Securities lowered shares of agilon health from an “outperform” rating to a “market perform” rating in a research report on Monday, November 11th. Three equities research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have assigned a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $5.20.

Insider Activity

In related news, CEO Steven Sell acquired 20,000 shares of the company’s stock in a transaction that occurred on Thursday, September 12th. The stock was acquired at an average price of $3.36 per share, for a total transaction of $67,200.00. Following the completion of the acquisition, the chief executive officer now owns 67,590 shares of the company’s stock, valued at $227,102.40. This trade represents a 42.03 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 3.20% of the company’s stock.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.